Pharmaceutical Technology Europe
Pharmaceutical Technology Europe-01-01-2014
Volume: 26
Issue: 1
Pharmaceutical Technology Europe-12-01-2013
Volume: 25
Issue: 12
Pharmaceutical Technology Europe-11-01-2013
Volume: 25
Issue: 11
Pharmaceutical Technology Europe-10-01-2013
Volume: 25
Issue: 10
Pharmaceutical Technology Europe-09-01-2013
Volume: 25
Issue: 9
Pharmaceutical Technology Europe-08-01-2013
Volume: 25
Issue: 8
Pharmaceutical Technology Europe-07-01-2013
Volume: 25
Issue: 7
Pharmaceutical Technology Europe-06-01-2013
Volume: 25
Issue: 6
Pharmaceutical Technology Europe-05-01-2013
Volume: 25
Issue: 5
Pharmaceutical Technology Europe-04-01-2013
Volume: 25
Issue: 4
Pharmaceutical Technology Europe-03-01-2013
Volume: 25
Issue: 3
Pharmaceutical Technology Europe-02-01-2013
Volume: 25
Issue: 2
Pharmaceutical Technology Europe-01-01-2013
Volume: 25
Issue: 1
Pharmaceutical Technology Europe-12-02-2012
Volume: 2012 Supplement
Issue: 2
Pharmaceutical Technology Europe-12-01-2012
Volume: 24
Issue: 12
Pharmaceutical Technology Europe-11-01-2012
Volume: 24
Issue: 11
Pharmaceutical Technology Europe-10-01-2012
Volume: 24
Issue: 10
Pharmaceutical Technology Europe-09-02-2012
Volume: 24
Issue: 9
Pharmaceutical Technology Europe-09-01-2012
Volume: 24
Issue: 9
Pharmaceutical Technology Europe-08-01-2012
Volume: 24
Issue: 8
Pharmaceutical Technology Europe-07-01-2012
Volume: 24
Issue: 7
Pharmaceutical Technology Europe-06-01-2012
Volume: 24
Issue: 6
Pharmaceutical Technology Europe-05-01-2012
Volume: 24
Issue: 5
Pharmaceutical Technology Europe-04-01-2012
Volume: 24
Issue: 4
Pharmaceutical Technology Europe-03-01-2012
Volume: 24
Issue: 3
Pharmaceutical Technology Europe-02-01-2012
Volume: 24
Issue: 2
Pharmaceutical Technology Europe-01-01-2012
Volume: 24
Issue: 1
Pharmaceutical Technology Europe-12-01-2011
Volume: 23
Issue: 12
Pharmaceutical Technology Europe-11-01-2011
Volume: 23
Issue: 11
Pharmaceutical Technology Europe-10-01-2011
Volume: 23
Issue: 10
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Duloxetine Recall Highlights Generic Manufacturing Quality Gaps
2
Germany Pharma Tariff Threat: What Manufacturers Need to Know
3
Why the First Generic Single-Dose Flu Antiviral Approval Matters
4
Is Compliant AI in Pharma Even Possible? The Search for an Honest Answer
5